364 related articles for article (PubMed ID: 35590394)
1. The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.
Zhang Z; Liu F; Chen W; Liao Z; Zhang W; Zhang B; Liang H; Chu L; Zhang Z
Exp Hematol Oncol; 2022 May; 11(1):30. PubMed ID: 35590394
[TBL] [Abstract][Full Text] [Related]
2. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
3. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Pan J; Huang T; Deng Z; Zou C
Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer.
Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726
[No Abstract] [Full Text] [Related]
5. RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma.
Li H; Hu J; Yu A; Othmane B; Guo T; Liu J; Cheng C; Chen J; Zu X
Front Oncol; 2021; 11():642159. PubMed ID: 33816290
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy.
Zhang MM; Lin YL; Zeng WF; Li Y; Yang Y; Liu M; Ye YJ; Jiang KW; Wang S; Wang S
Front Genet; 2021; 12():790888. PubMed ID: 34976022
[TBL] [Abstract][Full Text] [Related]
7. N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis.
Zhao W; Li J; Ma Q; Cai J; Li A; Wu W; Lv Y; Cai M
J Cell Physiol; 2022 Jul; 237(7):2729-2739. PubMed ID: 35342948
[TBL] [Abstract][Full Text] [Related]
8. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification.
Sun X; Wang H; Pu X; Wu Y; Yuan X; Wang X; Lu H
Cancer Gene Ther; 2024 Jun; ():. PubMed ID: 38834772
[TBL] [Abstract][Full Text] [Related]
9. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
Meijing Z; Tianhang L; Biao Y
Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
[No Abstract] [Full Text] [Related]
10. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
11. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J
Front Genet; 2021; 12():752025. PubMed ID: 35046996
[No Abstract] [Full Text] [Related]
12. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
Zhang Y; Zhan L; Li J; Jiang X; Yin L
Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma.
Shen S; Yan J; Zhang Y; Dong Z; Xing J; He Y
Ann Transl Med; 2021 Jan; 9(1):59. PubMed ID: 33553352
[TBL] [Abstract][Full Text] [Related]
14. One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.
Ouyang X; Gong Y
Front Immunol; 2022; 13():912526. PubMed ID: 35720276
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration.
Zhao T; Qi J; Liu T; Wu H; Zhu Q
Front Med (Lausanne); 2022; 9():821710. PubMed ID: 35308519
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
[TBL] [Abstract][Full Text] [Related]
17. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
Zhang Z; Wei W; Wang H; Dong J
Front Oncol; 2021; 11():743990. PubMed ID: 34722298
[TBL] [Abstract][Full Text] [Related]
18. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.
Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R
Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630
[No Abstract] [Full Text] [Related]
19. RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential.
Sun X; Fu S; Yuan X; Pu X; Wang R; Wang X; Lu H
Cancer Gene Ther; 2023 Sep; 30(9):1209-1214. PubMed ID: 37221404
[TBL] [Abstract][Full Text] [Related]
20. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]